Variant report

Variant	rs34844715
Chromosome Location	chr11:18286206-18286207
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:18284620..18287566-chr11:18415998..18418094,2	K562	blood:
2	chr11:18283937..18286938-chr13:37573373..37575594,3	MCF-7	breast:

Variant related genes	Relation type
ENSG00000134333	Chromatin interaction
ENSG00000120697	Chromatin interaction
ENSG00000120699	Chromatin interaction

Extended variants
information (count: 4 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:2)

rs_ID	r²[population]
rs12800700	0.86[AFR][1000 genomes]
rs12803622	0.82[AFR][1000 genomes];0.88[AMR][1000 genomes];0.96[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:2 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv949248	chr11:17791822-18692687	Weak transcription Flanking Active TSS Strong transcription Enhancers Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	156 gene(s)	inside rSNPs	diseases
2	nsv428569	chr11:18194030-18350869	Active TSS Enhancers Weak transcription Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	33 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:20 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:18278400-18293200	Weak transcription	Aorta	Aorta
2	chr11:18281400-18289400	Weak transcription	Duodenum Mucosa	Duodenum
3	chr11:18282000-18286600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr11:18283600-18291000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr11:18283600-18301600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
6	chr11:18283800-18286800	Weak transcription	Adipose Nuclei	Adipose
7	chr11:18285200-18287800	Enhancers	Primary monocytes fromperipheralblood	blood
8	chr11:18285200-18289200	Weak transcription	Hela-S3	cervix
9	chr11:18285200-18291200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
10	chr11:18285200-18303200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
11	chr11:18285400-18300600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
12	chr11:18285600-18286800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
13	chr11:18285600-18286800	Weak transcription	Liver	Liver
14	chr11:18285600-18289800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr11:18285600-18308400	Weak transcription	Gastric	stomach
16	chr11:18285800-18287800	Enhancers	GM12878-XiMat	blood
17	chr11:18285800-18298800	Weak transcription	HSMMtube	muscle
18	chr11:18286000-18286400	Weak transcription	Primary B cells from peripheral blood	blood
19	chr11:18286200-18286800	Weak transcription	HepG2	liver
20	chr11:18286200-18287600	Enhancers	Breast Myoepithelial Primary Cells	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links